Statement Of Cash Flows [Abstract]

BioInvent International - Filing #689618

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-01-01
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
650,000 SEK
517,000 SEK
Interest received, classified as operating activities
606,000 SEK
248,000 SEK
Cash flows from (used in) operating activities
41 227 SEK
245 843 SEK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
12 377 SEK
13 260 SEK
Cash flows from (used in) investing activities
628 848 SEK
467 542 SEK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
6 362 SEK
5 924 SEK
Cash flows from (used in) financing activities
273 487 SEK
894 870 SEK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
396 588 SEK
181 485 SEK
Cash and cash equivalents
515 047 SEK
910 755 SEK
910 755 SEK
729 270 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.